Incidence of cardiotoxicity in anthracycline-based chemotherapy in lymphoma patients: a single centre experience

被引：0
|
作者：
Bloodworth, C. [1 ]
Etherington, A. [1 ]
Bowen, R. [1 ]
Rowntree, C. [1 ]
Gatto, S. [1 ]
Gallop-Evans, E. [2 ]
Elmusharaf, N. [1 ]
机构：
[1] Univ Hosp Wales, Haematol, Cardiff, Wales
[2] Velindre Hosp, Oncol, Cardiff, Wales
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH2020-EP
引用
收藏
页码：229 / 230
页数：2
相关论文
共 50 条
  • [1] Early and late onset cardiotoxicity following anthracycline-based chemotherapy in breast cancer patients: Incidence and predictors
    Serrano, Jose M.
    Mata, Rebeca
    Gonzalez, Iria
    Del Castillo, Silvia
    Muniz, Javier
    Morales, Luis J.
    Espinosa, Maria Jesus
    Moreno, Fernando
    Jimenez, Rosa
    Cristobal, Carmen
    Graupner, Catherine
    Talavera, Pedro
    Landaluce, Carlos Gutierez
    Curcio, Alejandro
    Alonso, Javier
    Guerra, Juan A.
    Alonso, Joaquin J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 382 : 52 - 59
  • [2] Late-onset cardiotoxicity in Anthracycline-based chemotherapy for breast cancer patients
    Mata Caballero, R.
    Serrano Antolin, J. M.
    Gonzalez Garcia, I. A.
    Muniz Garcia, J.
    Curcio Ruigomez, A.
    Gutierrez Landaluce, C.
    Morales Garcia, L. J.
    Del Castillo Arrojo, S.
    Guerra Martinez, J. A.
    Graupner Abad, C.
    Jimenez Hernandez, R. M.
    Cristobal Varela, C.
    Malon Gimenez, D.
    Talavera Calle, P.
    Alonso Martin, J. J.
    EUROPEAN HEART JOURNAL, 2016, 37 : 118 - 119
  • [3] EFFICACY OF THE ANTHRACYCLINE-BASED CHEMOTHERAPY IN ANGIOIMMUNOBLASTIC T CELL LYMPHOMA PATIENTS
    Lee, S.
    Kim, H.
    Kim, I.
    Lee, S. R.
    Kim, D. S.
    Choi, C. W.
    Kim, B. S.
    Park, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 352 - 352
  • [4] Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma
    Ferreri, AJM
    Campo, E
    Arnbrosetti, A
    Ilariucci, F
    Seymour, JF
    Willemze, R
    Arrigoni, G
    Rossi, G
    López-Guillermo, A
    Berti, E
    Eriksson, M
    Federico, M
    Cortelazzo, S
    Govi, S
    Frungillo, N
    Dell'Oro, S
    Lestani, M
    Asioli, S
    Pedrinis, E
    Ungari, M
    Motta, T
    Rossi, R
    Artusi, T
    Iuzzolino, P
    Zucca, E
    Cavalli, F
    Ponzoni, M
    ANNALS OF ONCOLOGY, 2004, 15 (08) : 1215 - 1221
  • [5] PATTERN OF CARDIAC SURVEILLANCE AMONG LYMPHOMA PATIENTS RECEIVING ANTHRACYCLINE-BASED CHEMOTHERAPY
    Hung, O. Y.
    Brown, J. R.
    Dai, T.
    Easley, K. A.
    Flowers, C. R.
    Parashar, S.
    CARDIOLOGY, 2015, 131 : 119 - 119
  • [6] Pattern of cardiac surveillance among patients with lymphoma receiving anthracycline-based chemotherapy
    Hung, Olivia Y.
    Brown, Jennifer R.
    Dai, Tian
    Easley, Kirk A.
    Flowers, Christopher R.
    Parashar, Susmita
    BMJ OPEN, 2015, 5 (10):
  • [7] Prediction of trastuzumab-induced cardiotoxicity in breast cancer patients receiving anthracycline-based chemotherapy
    Wafaa S. El-Sherbeny
    Nesreen M. Sabry
    Radwa M. Sharbay
    Journal of Echocardiography, 2019, 17 : 76 - 83
  • [8] Monitoring of cardiotoxicity in acute leukaemia patients treated with anthracycline-based chemotherapy and haematopoietic cell transplantation
    Horacek, J. M.
    Jebavy, L.
    Tichy, M.
    Pudil, R.
    Zak, P.
    Maly, J.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S63 - S64
  • [9] Troponin as a cardiotoxicity marker in breast cancer patients receiving anthracycline-based chemotherapy: A narrative review
    Simoes, Ricardo
    Silva, Luciana Maria
    Valle Mussi Cruz, Andre Luiz
    Fraga, Vanessa Gomes
    Sabino, Adriano de Paula
    Gomes, Karina Braga
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 107 : 989 - 996
  • [10] Longitudinal rotation: a new way to detect the cardiotoxicity of anthracycline-based chemotherapy in breast cancer patients
    Huang, Jun
    Yan, Zi-Ning
    Rui, Yi-Fei
    Shen, Dan
    Fan, Li
    Chen, Dong-Liang
    ONCOTARGET, 2017, 8 (41) : 70072 - 70083
12345